New Evidence Sheds Light on Stem Cell Transplantation for Progressive MS

(MedPage Today) -- Autologous hematopoietic stem cell transplantation (AHSCT) was not superior in preventing relapses or reducing disability progression than natalizumab (Tysabri) in progressive multiple sclerosis (MS), new research suggested...